Background: Omeprazole (OMP), a proton pump inhibitor, is a highly effective drug for the management of acid-related disorders. Infections resulting from cytotoxin antigen A (CagA) positive Helicobacter pylori strains have been associated with higher grades of gastric mucosal inflammation. Nuclear factor (NF)-kB activation has been reported to participate in H. pylori-induced gastritis in humans. The complex interaction of OMP on the H. pylori and NF-kB related molecular mechanisms within the gastric mucosa remains unclear. In the present study, we investigated OMP, specifically its effects on NF-kB activation, and COX-2, IL-6, and IL-8 production in gastric cells (Kato-III cells) treated with CagA positive (CagA þ ) and negative (CagA e ) H. pylori strains. Methods: Kato-III cells were stimulated with H. pylori water extracts (HPE) containing ATCC 43504 (CagA þ ) and ATCC 51932 (CagA e ) strains. NF-kB activation, inhibitory IkB expression and phosphorylation, and cyclooxygenase (COX)-2, interleukin (IL)-6, and IL-8 expression were assessed in the absence and presence of OMP. Results: Both CagA þ and CagA e HPE induced NF-kB activation, whereas OMP suppressed NF-kB activation in the CagA e strain. HPE demonstrated a similar effect on IkB protein expression in the absence and presence of OMP. OMP alone decreased IkB phosphorylation without promoting NF-kB and IkB expression. Additionally, both CagA þ and CagA e HPE induced COX-2 expression, but no significant effect on IL-6 and IL-8. However, OMP downregulated the transcription of COX-2, IL-6, and IL-8 in CagA e HPE treated cells. Conclusion: Using the Kato-III cells model, H. pylori induces NF-kB activation in a CagA-independent manner. Both CagA þ HPE and CagA e HPE induced COX-2 gene expression, but not for IL-6 and IL-8 expression. However, OMP suppressed NF-kB activation via a downregulation of IkB phosphorylation in CagA e HPE treated condition. OMP also suppressed CagA e H. pylori induced-transcription of proinflammatory COX-2, IL-6, and IL-8. OMP may provide different effects on CagA þ and CagA e H. pylori infection conditions.
Introduction
Helicobacter pylori colonize the stomach, where it can induce peptic ulcers, mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma. 1, 2 In human and animal studies, H. pylori has been shown to induce inflammationassociated gene expression, including the activation of nuclear factor (NF)-kB, and production of interleukin (IL)-6, 3 IL-8, 4, 5 and cyclooxygenase-2 (COX-2) expression. 6 NF-kB is a ubiquitous transcription factor that plays a major regulatory role in inflammation. In resting cells, NF-kB is retained within the cytoplasm and bound to a family of inhibitory IkB proteins. A variety of stimuli rapidly induce the translocation of NF-kB into the nucleus via the phosphorylation of IkB. 7 A H. pylori infection can induce the phosphorylation of IkB, which contributes to the activation of NF-kB. 8 Pathogenic strains of H. pylori carry a type IV secretion system (T4SS) responsible for the injection of the oncoprotein cytotoxin antigen A (CagA) into host cells. 9 However, H. pylori has also been demonstrated to induce NF-kB expression in a type IV secretion system-dependent, but CagA -independent manner. 10 IL-6, IL-8, and COX-2, as well as their transcriptional regulation, are, in part, under the control of NF-kB. 11e13 Proton pump (H þ /K þ -adenosine triphosphatase) inhibitors (PPIs) have been available in acid-suppressing agents since the mid-1980s. Having demonstrated measureable safety and effectiveness for the treatment of acid-related disorders, PPIs have been widely used for the treatment of gastric ulcers, duodenal ulcers, and reflux esophagitis. Omeprazole (OMP), the earliest PPI available, has been used for the treatment of acid-related disorders for decades, and has existed as a functional PPI longer than any other PPI in its initial form. In addition to its antiacid characteristic, the metabolic and molecular effects of PPI utilization, particularly when taken longterm have grown as issues of substantial discussion. Recently, PPIs have been described as potential antiproliferative agents and a resistance modulator both in in vitro and in vivo xenograft tumors of mice. 14, 15 However, the inhibitory or promotional effect of PPIs for gastric inflammation and carcinogenesis remains controversial. 16, 17 In animal models, H. pylori infection induces gastric cancer in Mongolian gerbils and transgenic expression of H. pylori protein CagA could induce gastrointestinal and hematopoietic neoplasms. 18, 19 The molecular mechanisms responsible for the anti-inflammatory effects of PPIs include its interference in NFkB activation, which attenuates chemokines expressions resulting in gastric mucosal inflammation, 20, 21 and inhibits adhesion molecule expression located on polymorphonuclear neutrophil as well as vascular endothelial cells. 22 The suggestion that PPIs could downregulate H. pylori-induced angiogenesis indicates that PPIs have therapeutic potential for carcinogenesis. 17 However, a recent animal study suggests that long-term PPI administration promotes development of adenocarcinoma, which is associated with the progression of atrophic corpus gastritis in Mongolian gerbils infected with H pylori. 16 The interaction of H. pylori, host, and PPIs may be a multifactor and complex process. The molecular mechanisms involved in the inhibitory effects of OMP on the expression of inflammatory-related mediators are not fully understood. Moreover, there is little molecular evidence relating to the effects of OMP on NF-kB activation and the expression of IL-6, IL-8, and COX-2 in H. pylori-infected gastric mucosa.
In the present study, we aimed to investigate the effects of OMP in CagA positive (CagA þ ) and negative (CagA e ) H.
pylori-treated gastric cells, specifically, the effects of OMP on NF-kB activation and phosphorylation of IkB. The extent expression of inflammatory mediators COX-2, IL-6, and IL-8 were also measured.
Methods

Materials
The pure compound OMP (SigmaeAldrich Japan, Tokyo, Japan) was dissolved into dimethylsulfoxide as stock solution, and diluted to appropriate experimental concentrations with RPMI1640 medium before use. All other chemicals were obtained from SigmaeAldrich.
Cell culture
The gastric cancer cell line Kato III was purchased from the Bioresource Collection and Research Center, Food Industry Research and Development Institute (Hsinchu, Taiwan). Kato III cells were cultured in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum, 100 units/mL of penicillin, and 100 mg/mL of streptomycin in a humidified incubator at 37 C and 5% CO 2 .
Bacterial strains and preparation of H. pylori water extract
H. pylori strain ATCC 43504 (CagA þ ) and H. pylori strain ATCC 51932 (CagA e ) were selected for this study. These strains were cultured for 3 days on horse blood agar plates in a microaerophilic milieu (15% CO 2 ) at 37 C. The H. pylori extracts (HPE) were prepared as previously described with some modifications. 23 Briefly, bacteria in the exponential growth phase were harvested with sterile cotton swabs from the blood agar plates, and suspended in distilled water, using a concentration of 1.0 mL per plate (from 10 9 to 10 10 bacteria). The cell suspension was kept at room temperature for 20 minutes before centrifugation at 20,000g for 15 minutes. The resultant supernatant was considered as the initial water extract. No preservatives were added, and the extract was stored at À70 C until further use. Before use, the water extract was thawed at room temperature and centrifuged at 30,000g for 20 minutes. To remove most of the high molecular weight material (i.e., primarily membrane vesicles and whole flagella), the supernatant was passaged through a 0.2 mm syringe-adapted filter (Millipore Corp., Bedford, MA, USA). The Bradford assay (Bio-Rad, Hercules, CA, USA) was used for quantitative protein determinations, with bovine serum albumin serving as the standard. The resulting extracts (200 mg/mL) were diluted to 0.1% (v/v) in growth medium before use. 23 
Western blot analysis
Kato-III cells were incubated for 18 hours in culture medium lacking supplements prior to treatment. Preparations were treated with HPE (200 ng/mL) in the absence or presence of OMP (10 À5 M) for 24 hours. Cells were then washed twice with ice-cold PBS, dislodged with a scraper, and lysed in 250 mL of sample buffer (i.e. 62.5 mM of TriseHCl, 2% of SDS, 10% of glycerol, 50 mM of dithiothreitol, and 0.1% of bromophenol blue; pH 6.8). Proteins (15e20 mg) were separated via 10% SDS-polyacrylamide gel electrophoresis and transferred electrophoretically onto nitrocellulose membranes. Membranes were then blocked with buffer (i.e.. 20 mM of TriseHCl, 140 mM of NaCl, 0.1% of Tween 20, and 5% of skim milk powder; pH 7.6) and probed with primary anti-NF-kB, anti-IkB, anti-phosphorylated IkB (Cell Signaling Technology; Beverly, MA, USA), and anti-b actin (SigmaeAldrich) antibodies. The bound antibodies were detected with horseradish peroxidase-conjugated anti-mouse antibodies via an enhanced chemiluminescence ECL system (Amersham, Buckinghamshire, UK) and exposure of membranes to Kodak X-Omat films.
Quantitative real-time polymerase chain reaction
Kato-III cells were incubated for 18 hours in culture medium lacking supplements prior to treatments. Preparations were treated with HPE (200 ng/mL) in the absence or presence of OMP (10 À5 M) for 24 hours. Total RNA of extracts was obtained using the total RNA Isolation kit according to the manufacturer's instructions (Qiagen GmbH, Hilden, Germany). The yield and purity of extracted RNA were determined using the 260:280 nm absorbance ratio. The reverse transcription reaction was performed with 2 mg of total RNA, which was previously reverse transcribed into cDNA with oligo (dT) primers. The quantitative real time polymerase chain reaction (qPCR) analysis was carried out with an iScript cDNA synthesis kit (Bio-Rad, Berkeley, CA, USA.). All cDNA preparations were diluted at a 1:10 ratio with RNase free water before qPCR. All qPCR reactions were performed in a total volume of 25 mL, consisting of 1 mL of cDNA, 12.5 mL of iQ SYBR Green supermix (2Â; Bio-Rad) primer pairs, as listed in Table 1 . Each biological replicate was run in triplicate on a CFX96 real-time PCR detection system (BioRad). The cycling conditions were 10 minutes of polymerase activation at 95 C followed by 40 cycles at 95 C for 15 seconds and 65 C for 60 seconds. The threshold was set above the nontemplate control background and within the linear phase to target gene amplification and calculate the cycle at which the transcript was detected. Melting curves were also generated to confirm the single gene-specific peak, and nontemplate controls were included in each run to control for contaminations.
Statistical analysis
All experiments were carried out at least three times; data points in each assay represent measurement means from triplicate samples. Data are expressed as mean ± standard deviation. Differences between two groups were determined via the independent t test. In all cases, a p < 0.05 was considered to be statistically significant.
Results
Effects of OMP on NF-kB activation in Kato-III cells
As shown in Fig. 1 , both CagA þ and CagA À HPE (10%) induced NF-kB activation. CagA À HPE-induced NF-kB activation was suppressed with a cotreatment of OMP. An incubation of these cells in HPE with or without OMP did not affect the expression of IkB. However, the phosphorylation of IkB was clearly suppressed by an OMP treatment of these cells with or without CagA e HPE.
Effects of HPE and OMP on COX-2 expression in Kato-III cells
The treatment of Kato-III cells with CagA þ or CagA À HPE increased the expression of COX-2 mRNA (Fig. 2) . Furthermore, treatment with OMP alone did not affect the expression of COX-2. OMP reduced COX-2 transcription following CagA À HPE treatment. Conversely, OMP augmented COX-2 transcription induced via CagA þ HPE.
Effects of HPE and OMP on IL-6 expression in Kato-III cells
The treatment of Kato-III cells with CagA þ or CagA À HPE did not affect IL-6 mRNA expression (Fig. 3) . OMP treatment alone reduced IL-6 expression. Additionally, CagA À HPE cotreatment with OMP also suppressed IL-6 expression.
Effects of HPE and OMP on IL-8 expression in Kato-III cells
The treatment of Kato-III cells with OMP, CagA þ or CagA À HPE alone did not affect IL-8 mRNA expression significantly (Fig. 4) . However, cotreatment of OMP with CagA À HPE, OMP suppressed CagA À HPE-induced IL-8 transcription. 24, 25 An infection resulting from the CagA þ H. pylori has been associated with higher grades of gastric mucosal inflammation and severe atrophic gastritis, and is thought to play an important role in the development of gastric carcinoma.
25e28 CagA is a bacterium-derived oncoprotein that acts in mammals, which further indicates the importance of CagA tyrosine phosphorylation. This enables CagA to deregulate the proteinetyrosine phosphatase SHP-2 in the development of H. pylori-associated neoplasms. Transgenic expression of H. pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. 19 Furthermore, NF-kB could trigger H. pylori-initiated gastritis by inducing proinflammatory cytokines. Most stimuli activate NF-kB via the IkB kinase-mediated phosphorylation of inhibitory molecules (e.g., IkB at N-terminal serine residues). Although the evidence concerning the mechanisms that may regulate NF-kB in an H. pylori infection is equivocal, it appears that IkB kinase activity is required. 29 H. pylori induces NF-kB in a CagA-independent manner. 10 Our findings corroborate this observation, as we found that the stimulation of cells with both CagA þ and CagA e HPE resulted in the nuclear translocation of NF-kB. We also demonstrated that CagA þ H. pylori may possess a more remarkable effect on NF-kB activation than the CagA À strain due to its unapparent IkB phosphorylation. Furthermore, the amplified activation of NF-kB was clearly prevented with OMP treatment in CagA À HPE treated condition. Additionally, with CagA þ HPE treatment, OMP promoted COX-2 expression, but not for IL-6 and IL-8 expression. On the contrary, OMP suppressed COX-2, IL-6, and IL-8 expression in CagA À HPE-treated cells. These results suggest that OMP dysregulates NF-kB activation and suppresses COX-2, IL-6, and IL-8 production in Kato-III cells model. Possibly, OMP may have different molecular effects in CagA þ and CagA À H. pylori infections. OMP is widely used clinically due to its potent inhibitory effects on acid secretion. Furthermore, OMP appears to have a wide therapeutic range, in that it not only inhibits acid secretion, 30, 31 but also may possess anti-inflammatory 20 and anticancer properties 22 ; however, its underlying molecular mechanisms remain unclear. The mechanisms by which OMP suppresses gastric acid secretion have been shown to be dependent on its inhibition of the H þ /K þ ATPase present on the membrane of gastric parietal cells, and subsequent inhibition of H þ release. In addition, OMP can affect the transmigration of leukocytes from vessels to inflammatory sites via several mechanisms. OMP can inhibit the expression of adhesion molecules on neutrophils and vascular endothelial cells, as well as the proinflammatory response by suppressing IL-8 production in gastric and endothelial cells via the prevention of NF-kB nuclear translocation and activation. 20 To determine whether other PPIs such as lanoprazole, pantoprazole, and esomeprazole also have similar responses as those of OMP found in our study requires further study. The extent to which normal gastric mucosa also has a similar response to the Kato-III cell line, a human gastric cancer cell line, also necessitates additional clarification.
The interactions of H. pylori CagA proteins, host cells, and PPIs are complex processes, which possibly related to gastric inflammation and carcinogenesis. OMP attended the complex signaling processes of H. pylori infections and is involved in antiproliferative and anti-inflammatory mechanisms.
